Home » Newsletters » BioWorld Science

BioWorld Science

April 19, 2018

View Archived Issues

Cystic Fibrosis Foundation TDN endorses phase II study protocol for PTI-428

Tecentriq launched in Japan for the treatment of unresectable advanced or recurrent NSCLC

AiCuris and Max Planck to identify novel compounds for treatment of viral and bacterial infections

Bayer presents a novel SMYD3 inhibitor probe

First subject dosed in phase I/IIa trial of SYNB-1618 for the treatment of phenylketonuria

AntoXa Corporation obtains license from DRDC for plant-made PhD9 anti-ricin antibody

Artelo Biosciences licenses IP portfolio of fatty acid binding protein inhibitors

Preclinical evaluation of novel HERA-LIGHT fusion protein for cancer immunotherapy

FDA grants fast track designation CB-839 in combination with cabozantinib for treatment of RCC

Caspid modulator GLP-26 shows promise for drug-resistant hepatitis B virus infection

AstraZeneca launches Lynparza in Japan

Fasenra for asthma now available in Japan

FDA approves Tagrisso for first-line NSCLC

AstraZeneca and Daiichi Sankyo launch new formulation of Nexium

Taiho presents highly selective RET inhibitor TAS-0286

Opiant Pharmaceuticals receives grant to develop intranasal nalmefene

Mercaptor develops new class of drugs called captons

Cancer Research Technology patents new CDC7 inhibitors

Cellipse identifies LIMK-1 and/or LIMK-2 inhibitors

Procter & Gamble to acquire Merck KGaA's consumer health business

FDA grants priority review to sBLA for Opdivo in previously treated SCLC

Institut Pasteur Korea divulges new compounds for influenza

Pear Therapeutics and Sandoz sign agreement for prescription digital therapeutics

Novel compound targets multiple immune checkpoint elements

New EHMT1 and/or EHMT2 inhibitors presented by Epizyme

Boehringer Ingelheim patents hSTING agonists

FDA grants rare pediatric disease designation to sevuparin for children with sickle cell disease

Qu Biologics initiates phase II trial for QBECO in Crohn's disease

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...